Abstract Rationale Abnormal tissue repair and excessive extracellular matrix (ECM) deposition driven by the transition of fibroblasts into myofibroblasts characterizes idiopathic pulmonary fibrosis (IPF), a progressive fibrosing interstitial pneumonia. IPF carries a poor prognosis due to limited therapeutic options. Several G-protein coupled receptors (GPCRs) are impugned in the pathogenesis of IPF. In this study, we posit an interplay between G-protein families and TGF-β, a key regulator of ECM remodeling and fibrosis in human lung fibroblasts (HLF). Methods As a model of lung fibrosis, primary HLF were stimulated with TGF-β; collagen 1A1 and plasminogen activator inhibitor-1 (PAI) expression were then measured in the presence and absence of soluble receptor inhibitors (Gαq inhibitors) and decreased receptor expression with siRNA (Gα12 and Gαs siRNA). All experiments were performed in n ≥ 3 unique cell lines. Results TGF-β significantly induced collagen 1A1 (p = 0.03) and PAI (p = 0.02) in HLF. TGF-β induced collagen 1A1 (n = 9; p = 0.03) and PAI (n = 6; p = 0.03) was unaffected by Gαs knockdown. Treatment with the Gαs agonist (treprostinil) significantly inhibited TGF-β-induced collagen 1A1 (n = 6, p = 0.04). The treprostinil inhibitory effects was partially reversed following Gαs knockdown (n = 6, p = 0.05), suggesting that Gαs mediates treprostinil’s suppression of collagen 1A1. In contrast, Gαs was not required for treprostinil-mediated inhibition of PAI (n = 6, p = 0.03). The efficiency of Gαs knockdown exceeded 90%. A dose-response of the soluble Gαq inhibitor (100nM to 1µM) failed to alter TGF-β-induced collagen 1A1 or PAI expression (n = 4). In contrast, TGF-β-induced collagen 1A1 expression was reduced by Gα12 knockdown (n = 3, p = 0.05) while PAI remained unaffected. These findings suggest that Gα12 specifically mediates TGF-β-induced collagen 1A1 expression but not PAI. Conclusions Gα12 functions as a profibrotic G protein involved in TGF-β-induced collagen 1A1 expression. Elucidating the interplay between GPCR signaling, particularly the Gα12 subunit, and TGF-β may identify novel therapeutic strategies for IPF. This abstract is funded by: None
McNamara et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: